Recursion Pharmaceuticals Other Operating Income or Expenses 2020-2025 | RXRX
Recursion Pharmaceuticals other operating income or expenses from 2020 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.